GENI vs SRAD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
GENI
SRAD
Investment Advisor Scores
SRAD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | GENI | SRAD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 56.8182 | 48.3092 | SRAD |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 64.7% | 18.9% | GENI |
| Earnings Growth | 0.0% | -39.9% | GENI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 44.4/100 | 69.3/100 | SRAD |
| Profit Margin | -23.0% | 1.2% | SRAD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | STRONG BUY | SRAD |
Relative Price Performance (Last 90 Days)
Current Technical Phase
GENI
MarkupPrice above SMA50, rising 50-day trend (14.0% over 20 days), RSI 60
SRAD
MarkdownPrice below a falling SMA50 (slope -0.6%), weak momentum, RSI 44
Fundamentals Snapshot
| Metric | GENI | SRAD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.5 | 26.3 |
| Trailing P/E | — | 210.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.6% | 0.2% |
| Gross Margin | 0.3% | 0.3% |
| Operating Margin | -0.1% | 0.1% |
| EPS | -0.70 | 0.06 |
| Dividend Yield | — | — |